治疗性α-1-微型球蛋白可以改善脏缺血-再输液损伤
Mikhail Burmakin1,2, Peter S Gilmour2, Magnus Gram3,4,5
1Division of Pathology, Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden.
American journal of physiology. Renal physiology
|May 23, 2024
概括
改性α-1-微球蛋白 (A1M) 蛋白质RMC-035在缺血-再输液损伤模型中显示出显著的保护. 这种试验性疗法针对氧化应激和炎症,支持其用于保护的临床开发.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔法-1-微型球蛋白 (A1M) 是一种具有抗氧化和保护功能的糖蛋白.
- 缺血再输液损伤 (IRI) 是一个重大的临床挑战.
- RMC-035是一种修改后的A1M蛋白,用于治疗目的.
研究的目的:
- 评估RMC-035.5的生物分布和药理活性.
- 在脏IRI的临床前模型中评估RMC-035的疗效.
- 为了支持RMC-035作为脏保护疗法的临床开发.
主要方法:
- 进行了体外和体内实验.
- 使用光标记RMC-035.5进行生物分布评估.
- 在大鼠和小鼠的IRI模型中评估了疗效,测量了GFR,脏生物标志物和组织病理学.
主要成果:
- 在各种IRI模型中,RMC-035显示出一致的脏保护,降低了小鼠的死亡率.
- 观察到最佳的疗效与结合的前和后缺血的剂量.
- 分布到脏的RMC-035,抑制了IRI诱导的血氧酶-1,减少了炎症,并改善了线粒体功能.
结论:
- RMC-035表现出有针对性的机制和有利于脏保护的生物分布特征.
- 临床前数据支持继续对RMC-035进行临床评估,以保护脏.
- 对于患有损伤风险的患者来说,RMC-035是一种有前途的治疗候选药物.
更多相关视频
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
1.6K
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
2.2K
相关概念视频
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...